Efficacy and Safety Study of ATs in Patients With Dry Eye Syndrome
NCT00788229
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
72
Enrollment
INDUSTRY
Sponsor class
Conditions
Dry Eye Syndromes
Keratoconjunctivitis Sicca
Interventions
DRUG:
AT01
DRUG:
AT02
DRUG:
AT03
DRUG:
AT04
Sponsor
Dhp Korea Co., Ltd.